Pathology

Cell Block Prep Method Modified for Molecular Studies
Biomarker testing is currently required to guide the selection of a growing number of targeted therapies in patients with a wide range of malignancies. Combined with increasing use of immunostaining for tumor diagnosis, this has substantially increased the demand for the amount of tissue in small specimens. More...14 May 2018

Thyroid Cancer Genetics Study Finds New Mutations
Anaplastic thyroid cancer (ATC) is a form of thyroid cancer, which has a very poor prognosis due to its aggressive behavior and resistance to cancer treatments. Its anaplastic cells have poor differentiation, including dedifferentiation. More...08 May 2018
Breath and Urine Tests Detect Early Breast Cancer
Breast cancer is the most commonly diagnosed malignancy among females and the leading cause of death around the world. In 2016, breast cancer accounted for 29% of all new cancers identified in the USA and was responsible for 14% all cancer-related deaths. More...08 May 2018

Biomarkers Identified for Irritable Bowel Syndrome
The causes of gastrointestinal complaints in irritable bowel syndrome (IBS) remain poorly understood. Altered nerve function has emerged as an important pathogenic factor as IBS mucosal biopsy supernatants consistently activate enteric and sensory neurons. More...02 May 2018
Cancer Blood Test Engineered to Detect Tumors Early
A new innovative microfluidic device has been developed that uses magnetic particles and wavy-herringbone design to capture and release circulating tumor cells (CTC) with a high capture efficiency rate at different tumor cell concentrations. More...02 May 2018

Streamlined Approach Discovered for Treating Bowel Cancer
More than 4,000 Australians die from bowel cancer each year, and more than 17,000 new cases of this cancer will be diagnosed in 2018. Scientists are working to understand the genetic drivers of bowel cancer, with a special interest in those cancers which are the hardest to treat, and which have the poorest prognosis. More...02 May 2018
In Other News
Molecular Technology Identifies Potential Biomarker for Cancer
Image Analysis System Quantifies NASH Disease Activity
Genetic Variant Identified As Better Marker for CV Disease
Amyloid Blood Biomarker Detects Alzheimer's Disease
Confocal Fluorescence Microscopy Used for Rapid Tissue Evaluation
Sampling Device Increases Detection of Barrett’s Esophagus
Aggressive Meningioma Linked to Transcription Factor Activity
Gut Microbiome Analysis Predicts Hospitalizations in Cirrhosis
Genomic Test Detects Lynch Syndrome in Colorectal Cancer
Novel RNA Blood Test Launched for Fibromyalgia
Liquid Biopsy Can Rule Out Early-Stage Lung Cancer
Urinary Gene-Based Test Detects Bladder Cancer
Cervical Fluid Test Developed for Gynecological Cancers
Chromosome Interaction Profiling Reveals Cancer Risk Genes
Cutting Edge Technology Used to Grade Cancer Tumors
Distinct Epigenetic Features Found in Alzheimer's Brains
Microfluidic Device Captures Tumor-Specific Extracellular Vesicles
Non-Invasive Urine Test Detects Prostate Cancer
Blood Test Predicts Patient Response to Chemotherapy
Elevated Mir-24-3p Plays Prognostic Role in Breast Cancer
Cancer Stem Cells Isolated Using Novel Method
New Staining Method Enables Nano-CT Imaging of Tissue
Multigene Breast Cancer Recurrence Signatures Tests Compared
The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.







